Why is $AKBA moving today? · SEC 8-K archive

$AKBA SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $AKBA: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $AKBA filing catalyst

Why did $AKBA trigger an AI stock catalyst alert?

$AKBA triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -4.5/10). Headline: Akebia Therapeutics Reports Q3 Net Loss of $14.4M on Revenue Contraction. Key points: - Total revenues dropped to $36.9M from $58.8M year-over-year; net loss widened to $(14.4)M or $(0.05) per share from a profit of $0.5M. - Vafseo net product revenues reached $14.8M, sequentially lower due to customer inventory reduction. - Active Vafseo patients grew 8.1% quarter-over-quarter to 11,500 amid upcoming TDAPA expiration.

How did $AKBA stock react after the SEC filing?

After the SEC 8-K for $AKBA, observed market reaction: T0 price $0.70; 4h move -33.99%; peak move +34.88%. Past moves do not guarantee future results.

Where can I get real-time $AKBA SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $AKBA via Telegram and the VIP Web Terminal from €10/month.

$AKBA

$AKBA – Akebia Therapeutics Reports Q3 Net Loss of $14.4M on Revenue Contraction

Akebia Therapeutics, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $AKBA

Unlocked archive · Analyzed in <2s at T0

Bearish AI Sentiment (-4.5 / 10)

Total revenues dropped to $36.9M from $58.8M year-over-year; net loss widened to $(14.4)M or $(0.05) per share from a profit of $0.5M.
Vafseo net product revenues reached $14.8M, sequentially lower due to customer inventory reduction.
Active Vafseo patients grew 8.1% quarter-over-quarter to 11,500 amid upcoming TDAPA expiration.

Observed market reaction after signal

4h -33.99% · Peak +34.88%

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →